A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: mature (29), experienced (1000)

Annual-report-201617

Description
ANNUAL REPORT AND ACCOUNTS 2016/17 incorporating the quality account 2016/17 Presented to Parliament pursuant to Schedule 7, paragraph 25 (4) (a) of t
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2016171.pdf

Vismodegib

Description
Chemotherapy Protocol BASAL CELL CARCINOMA (BCC) VISMODEGIB Regimen  BCC - Vismodegib Indication  The patient either has; a. Gorl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Vismodegib.pdf

Cisplatin (35) Gemcitabine ver1.1

Description
Chemotherapy Protocol BLADDER CISPLATIN (35)-GEMCITABINE Regimen Bladder-Cisplatin (35)-Gemcitabine Indication For use in patients unable to tolerate standard cisplatin (70)-gemcitabine due
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-35-Gemcitabine-ver1.1.pdf

Paclitaxel (7 day)

Description
Chemotherapy Protocol BREAST CANCER PACLITAXEL (7 day) Regimen • Breast Cancer – Paclitaxel (7 day) Indication • Treat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-7-day.pdf

Cisplatin Etoposide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-ETOPOSIDE (Oral) Regimen Ovary-Cisplatin-Etoposide PO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CisplatinEtoposidePO.pdf

Cisplatin and Etoposide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-ETOPOSIDE (oral) Regimen Uterine-Cisplatin-Etoposide
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CisplatinEtoposidePO.pdf

Cisplatin and Topotecan

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-TOPOTECAN (intravenous) Regimen Cervix-Cisplatin-Topotecan IV Indication Recurrent stage IVB cervical cancer in patients
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/CisplatinandTopotecan.pdf

Cisplatin and Etoposide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-ETOPOSIDE (oral) Regimen Cervix-Cisplatin-Etoposide P
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/CisplatinandEtoposidePO.pdf

Cisplatin (40) and Radiotherapy

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN (40)-RADIOTHERAPY Regimen Cervix-Cisplatin (40)-Radiotherapy Indication Locally advanced cervical, vaginal and vulval
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Cisplatin40andRadiotherapy.pdf

ACCORD-2 master protocol

Description
CONFIDENTIAL ACCORD-2-001 – Master Protocol TITLE PAGE Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-master-protocol.pdf
91 to 100 of 119
Previous … 8 9 10 11 12 Next